ASV Therapy for Insomnia

NANot yet recruitingINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

August 31, 2025

Primary Completion Date

August 31, 2026

Study Completion Date

August 31, 2026

Conditions
InsomniaInsomnia (Moderate)
Interventions
DEVICE

ASV therapy

Adaptive servo ventilation (ASV) therapy using ResMed AirCurve 11 device will be used to target potential upper airway resistance and respiratory related arousals in patients with insomnia. The ASV device is approved for the treatment of obstructive sleep apnea, and this will be designated as the investigational device for this study with appropriate labelling.

Trial Locations (1)

48201

C.S. Mott Center, Detroit

Sponsors

Lead Sponsor

All Listed Sponsors
lead

ResMed

INDUSTRY